TFS Capital’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-23,683
| Closed | -$330K | – | 423 |
|
|
2017
Q2 | $330K | Buy |
+23,683
| New | +$330K | 0.13% | 311 |
|
|
2017
Q1 | – | Sell |
-22,749
| Closed | -$234K | – | 906 |
|
|
2016
Q4 | $234K | Buy |
22,749
+3,649
| +19% | +$37.5K | 0.06% | 466 |
|
|
2016
Q3 | $193K | Buy |
19,100
+656
| +4% | +$6.63K | 0.05% | 566 |
|
|
2016
Q2 | $207K | Sell |
18,444
-114,740
| -86% | -$1.29M | 0.04% | 719 |
|
|
2016
Q1 | $1.82M | Buy |
133,184
+29,050
| +28% | +$397K | 0.26% | 90 |
|
|
2015
Q4 | $1.98M | Sell |
104,134
-278,062
| -73% | -$5.27M | 0.21% | 167 |
|
|
2015
Q3 | $7.17M | Buy |
382,196
+330,669
| +642% | +$6.21M | 0.69% | 2 |
|
|
2015
Q2 | $767K | Buy |
51,527
+16,129
| +46% | +$240K | 0.07% | 406 |
|
|
2015
Q1 | $536K | Sell |
35,398
-89,104
| -72% | -$1.35M | 0.05% | 525 |
|
|
2014
Q4 | $1.66M | Buy |
124,502
+100,404
| +417% | +$1.34M | 0.16% | 184 |
|
|
2014
Q3 | $304K | Buy |
24,098
+7,921
| +49% | +$99.9K | 0.03% | 742 |
|
|
2014
Q2 | $163K | Buy |
+16,177
| New | +$163K | 0.01% | 988 |
|